Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Talecris Biotherapeutics Holdings Corp. (TLCR) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Talecris Biotherapeutics Holdings Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 1405197.
Total stock buying since 2010: $0.
Total stock sales since 2010: $32,838,807.
Total stock option exercises since 2010: $8,582,788.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2011 | 0 | $0 | 219,394 | $5,184,775 | 209,394 | $867,654 |
| 2010 | 0 | $0 | 1,230,345 | $27,654,032 | 1,087,110 | $7,715,134 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2011-02 | 0 | $0 | 94,697 | $2,307,224 | 89,697 | $268,827 |
| 2011-01 | 0 | $0 | 124,697 | $2,877,551 | 119,697 | $598,827 |
| 2010-12 | 0 | $0 | 52,408 | $1,126,772 | 47,408 | $65,896 |
| 2010-11 | 0 | $0 | 83,786 | $2,041,936 | 78,786 | $109,510 |
| 2010-10 | 0 | $0 | 138,042 | $3,150,046 | 133,042 | $473,226 |
| 2010-09 | 0 | $0 | 639,147 | $14,364,721 | 574,434 | $4,509,303 |
| 2010-08 | 0 | $0 | 316,962 | $6,970,557 | 253,440 | $2,557,199 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-02-01 | Petteway Stephen R Jr (Executive VP, R&D) | Sale | 25,000 | 24.37 | 609,200 |
| 2011-02-01 | Petteway Stephen R Jr (Executive VP, R&D) | Option Ex | 20,000 | 1.39 | 27,799 |
| 2011-02-01 | Abelson Joel E (Sr VP & GM, Int'l Bus.) | Sale | 15,000 | 24.38 | 365,715 |
| 2011-02-01 | Abelson Joel E (Sr VP & GM, Int'l Bus.) | Option Ex | 15,000 | 11.00 | 165,000 |
| 2011-02-01 | Kuhn Mary J (Executive VP, Operations) | Sale | 54,697 | 24.36 | 1,332,309 |
| 2011-02-01 | Kuhn Mary J (Executive VP, Operations) | Option Ex | 54,697 | 1.39 | 76,028 |
| 2011-01-03 | Petteway Stephen R Jr (Executive VP, R&D) | Sale | 25,000 | 23.06 | 576,600 |
| 2011-01-03 | Petteway Stephen R Jr (Executive VP, R&D) | Option Ex | 20,000 | 1.39 | 27,799 |
| 2011-01-03 | Abelson Joel E (Sr VP & GM, Int'l Bus.) | Sale | 45,000 | 23.08 | 1,038,599 |
| 2011-01-03 | Abelson Joel E (Sr VP & GM, Int'l Bus.) | Option Ex | 45,000 | 11.00 | 495,000 |
| 2011-01-03 | Kuhn Mary J (Executive VP, Operations) | Sale | 54,697 | 23.08 | 1,262,352 |
| 2011-01-03 | Kuhn Mary J (Executive VP, Operations) | Option Ex | 54,697 | 1.39 | 76,028 |
| 2010-12-01 | Petteway Stephen R Jr (Executive VP, R&D) | Sale | 25,000 | 21.50 | 537,500 |
| 2010-12-01 | Petteway Stephen R Jr (Executive VP, R&D) | Option Ex | 20,000 | 1.39 | 27,799 |
| 2010-12-01 | Engle James R (Sr. VP, Information Technology) | Sale | 27,408 | 21.50 | 589,272 |
| 2010-12-01 | Engle James R (Sr. VP, Information Technology) | Option Ex | 27,408 | 1.39 | 38,097 |
| 2010-11-01 | Petteway Stephen R Jr (Executive VP, R&D) | Sale | 25,000 | 24.37 | 609,250 |
| 2010-11-01 | Petteway Stephen R Jr (Executive VP, R&D) | Option Ex | 20,000 | 1.39 | 27,799 |
| 2010-11-01 | Engle James R (Sr. VP, Information Technology) | Sale | 12,656 | 24.37 | 308,452 |
| 2010-11-01 | Engle James R (Sr. VP, Information Technology) | Option Ex | 12,656 | 1.39 | 17,591 |
| 2010-11-01 | Kuhn Mary J (Executive VP, Operations) | Sale | 46,130 | 24.37 | 1,124,234 |
| 2010-11-01 | Kuhn Mary J (Executive VP, Operations) | Option Ex | 46,130 | 1.39 | 64,120 |
| 2010-10-01 | Petteway Stephen R Jr (Executive VP, R&D) | Sale | 25,000 | 22.81 | 570,150 |
| 2010-10-01 | Petteway Stephen R Jr (Executive VP, R&D) | Option Ex | 20,000 | 1.39 | 27,799 |
| 2010-10-01 | Engle James R (Sr. VP, Information Technology) | Sale | 36,912 | 22.81 | 841,962 |
| 2010-10-01 | Engle James R (Sr. VP, Information Technology) | Option Ex | 36,912 | 1.39 | 51,307 |
| 2010-10-01 | Abelson Joel E (Sr VP & GM, Int'l Bus.) | Sale | 30,000 | 22.82 | 684,510 |
| 2010-10-01 | Abelson Joel E (Sr VP & GM, Int'l Bus.) | Option Ex | 30,000 | 11.00 | 330,000 |
| 2010-10-01 | Kuhn Mary J (Executive VP, Operations) | Sale | 46,130 | 22.84 | 1,053,424 |
| 2010-10-01 | Kuhn Mary J (Executive VP, Operations) | Option Ex | 46,130 | 1.39 | 64,120 |
| 2010-09-16 | Heerdt Kari D (Sr. VP, Human Resources) | Sale | 108,000 | 23.06 | 2,490,588 |
| 2010-09-16 | Heerdt Kari D (Sr. VP, Human Resources) | Option Ex | 108,000 | 11.00 | 1,188,000 |
| 2010-09-14 | Kuhn Mary J (Executive VP, Operations) | Sale | 33,000 | 23.01 | 759,396 |
| 2010-09-13 | Nogales Bruce (Sr. VP & GM, Plasma Resources) | Sale | 18,370 | 22.96 | 421,720 |
| 2010-09-13 | Nogales Bruce (Sr. VP & GM, Plasma Resources) | Option Ex | 18,370 | 1.39 | 25,534 |
| 2010-09-10 | Nogales Bruce (Sr. VP & GM, Plasma Resources) | Sale | 7,070 | 22.95 | 162,256 |
| 2010-09-10 | Nogales Bruce (Sr. VP & GM, Plasma Resources) | Option Ex | 7,070 | 1.39 | 9,827 |
| 2010-09-03 | Lynch Thomas J (Sr. VP, Corp. Compliance) | Sale | 113,440 | 22.50 | 2,552,400 |
| 2010-09-03 | Lynch Thomas J (Sr. VP, Corp. Compliance) | Option Ex | 113,440 | 6.20 | 702,760 |
| 2010-09-02 | Perkins John R Ii (EVP, Global Commercial) | Sale | 237,937 | 22.30 | 5,306,946 |
| 2010-09-02 | Perkins John R Ii (Sr.VP & GM, Portfolio & US Bus) | Option Ex | 213,324 | 11.00 | 2,346,564 |
| 2010-09-01 | Perkins John R Ii (Sr.VP & GM, Portfolio & US Bus) | Sale | 10,200 | 22.30 | 227,460 |
| 2010-09-01 | Perkins John R Ii (Sr.VP & GM, Portfolio & US Bus) | Option Ex | 8,100 | 11.00 | 89,100 |
| 2010-09-01 | Petteway Stephen R Jr (Executive VP, R&D) | Sale | 25,000 | 21.99 | 549,825 |
| 2010-09-01 | Petteway Stephen R Jr (Executive VP, R&D) | Option Ex | 20,000 | 1.39 | 27,799 |
| 2010-09-01 | Nogales Bruce (Sr. VP & GM, Plasma Resources) | Sale | 40,000 | 21.99 | 879,640 |
| 2010-09-01 | Nogales Bruce (Sr. VP & GM, Plasma Resources) | Option Ex | 40,000 | 1.39 | 55,599 |
| 2010-09-01 | Kuhn Mary J (Executive VP, Operations) | Sale | 46,130 | 21.99 | 1,014,490 |
| 2010-09-01 | Kuhn Mary J (Executive VP, Operations) | Option Ex | 46,130 | 1.39 | 64,120 |
| 2010-08-30 | Menichella Daniel L (Sr. VP, Business Development) | Sale | 100,000 | 22.05 | 2,204,800 |
| 2010-08-30 | Menichella Daniel L (Sr. VP, Business Development) | Option Ex | 100,000 | 11.00 | 1,100,000 |
| 2010-08-27 | Engle James R (Sr. VP, Information Technology) | Sale | 18,489 | 22.03 | 407,386 |
| 2010-08-27 | Abelson Joel E (Sr VP & GM, Int'l Bus.) | Sale | 8,128 | 22.09 | 179,515 |
| 2010-08-26 | Nogales Bruce (Sr. VP & GM, Plasma Resources) | Sale | 37,005 | 22.00 | 813,924 |
| 2010-08-26 | Nogales Bruce (Sr. VP & GM, Plasma Resources) | Option Ex | 24,433 | 6.20 | 151,362 |
| 2010-08-25 | Nogales Bruce (Sr. VP & GM, Plasma Resources) | Sale | 29,500 | 21.92 | 646,728 |
| 2010-08-25 | Nogales Bruce (Sr. VP & GM, Plasma Resources) | Option Ex | 23,567 | 6.20 | 145,997 |
| 2010-08-25 | Abelson Joel E (Sr VP & GM, Int'l Bus.) | Sale | 105,440 | 21.89 | 2,307,976 |
| 2010-08-25 | Abelson Joel E (Sr VP & GM, Int'l Bus.) | Option Ex | 105,440 | 11.00 | 1,159,840 |
| 2010-08-19 | Heerdt Kari D (Sr. VP, Human Resources) | Sale | 18,400 | 22.30 | 410,228 |
Insider trading activities including stock purchases, stock sales, and option exercises of TLCR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Talecris Biotherapeutics Holdings Corp. (symbol TLCR, CIK number 1405197) see the Securities and Exchange Commission (SEC) website.